WORCESTER — On a Thursday in March, Jon Weaver, president and CEO of Massachusetts Biomedical Initiatives, had what he calls ...

Author: Matt Lawton, Executive Director, FSP Delivery, Syneos Health | Why Your Operating Model Should Reflect Your Company’s ...

The Centre brings together government, academia, industry and nutrition expertise on a common platform ...

Fidelity offers lower costs and steadier returns, while State Street targets smaller biotech companies with higher volatility ...

As an MIT Technology Review subscriber, you’ll get a 20% discount , meaning you can access the full EmTech Future 2026 program for just $596.

The sciences are an often-overlooked sector that has been hit hard by U.S. tariffs. In British Columbia, the infrastructure ...

The Australian pharma company believes the drug will be an important therapeutic option to improve kidney function.

A virtual biotech run by AI agents combed past drug trials and found that drugs with narrowly active targets were more likely to succeed.

Aroa Biosurgery Ltd (ASX:ARX, OTC:AROAF) has reported positive results from a US randomised controlled trial showing its Symphony wound care product significantly improved healing outcomes for ...

The pitch of the modern fertility industry is pure, unadulterated control. If a couple can’t conceive, technology intervenes.

"He knows firsthand what happens when global policy fails to translate into care on the ground" - Nicholas Sarlis, Chief Medical Officer of CLEARA Biotech, ...